So you are going to Sages?

I would agree with the point about Verb buying TRXC being good for Titan b/c the technology of SUrgibot and ALF is not first class or a significant innovative technological improvement of current technology. It would make me feel better about Titan's chances if they plan to go it alone and Verb bought TRXC

I am curious to see if Titan brings on a sales executive (US Based) before SAGES, if they do, I would think that is a very, very positive sign that they are closer to commercialization then we think.

Don't forget about the patents they pr about a month ago. The rotation end effectors was interesting.

Interesting that the rumor that was started about TRXC talked about a potential merger with Google or jnj. For us savvy investors, we know it isn't ONE OR THE OTHER. It appears to be pure manipulation bc they would have referred to either Verb or Google and jnj partnership. They have no idea of the robotic market.

they were joking, that's why they went with a volvo car

We've already qualified that Titan is going to be at Sages in 4-6 weeks, this information is not new.

I would agree with that, let's see what they have at Sages. If it is the product we think it is, it will get interesting.

can't wait until one patient isn't strapped in right and they slide right off the table during a procedure.

Really? You don't see anything coming to move the stock - WOW! Are you sure you are looking at Titan Medical with Sport, not the Titan Medical DME

Same for Jarrett but it's a mistake - I don't believe that Titan is hiring territory sales reps just yet

looks like any "sales" hire that appears to be Titan Medical is a DME company called Titan Medical.

The Marketing and Quality hires are for Titan Medical and SPORT

Interest in surgical robotics starting to gain traction. Saw another robotic company hit a 52 week low today (possible death cross?) for TRXC

Reminder that Coleman lannum works for bertner advisors

a guy that runs a smoothie king franchise in your local neighborhood is not really considered an executive. However, What has the smoothie king exec excited about the product?

Yes they are, they are begging for other options. ISRG has a reputation for being very unflexible and hard to work with.

If you sell now and they come out with the videos and show the snake arms and the rotating end effectors and complete the longtai deal - stock shoots up and you have lost out - all based on someones info who doesn't beleive in Titan - saying there will be more dilution due to financing is a fact with ANY STOCK, it's not a tidbit of info or a counterpoint. I don't think it is right if I were to lose a ton of money on my investment to want to make other investors lose money b/c I am up a creek without a paddle.

Only sell if you don't believe in the product, every indication is that they are on track to start selling in fall of this year. Titan has been developed for the future and the future is here. This will be the next surgical robotic platform to the market. Their patents are worth more than the current PPS. It's certainly possible they go back to the shelf but really would not like to see a reverse split (we've seen what that has done to other stocks, ie. TRXC - so much lost value by doing that)

Sure it has, that is part of what ximedica does. Check out what they do in developing a medical device. Maybe a company like TRXC trying to develop on their own w/o knowledge of the regulatory process (since they still have an opening for a regulatory specialist that they can't fill) might not have started the regulatory process that takes 9 months but Titan is way ahead of that.

Alf-x has been available for commercial sales in Europe for 3-4 years now (somewhere in that timeframe) and as a serious contender it must have 100's of millions of dollars in sales over that time but it doesn't. Not a serious contender - neither ALF or TRXC have the resources to updated their systems. Tech moves to fast and those platforms were built on what had been happening in robotics not what was going to happen.

They terms of the agreement/buyout should tell you all you need to know - $99M for a robotic platform that has been available for commercial sales for 3-4 years - that can't be good.

Actually Titan has begun the 510k process.

Nice find, another interesting fact, the automated pan/tilt camera that follow instrumentation will eliminate 30 minutes off of a 4 hour procedure. That's significant.

I'm confused, you said the unveiling was the photos that Titan posted but then you agreed that it wasn't the unveiling bc of mgmt.

That was not what I would call an unveiling.

As soon as they unveil the product the just finished, then it rises

The loudest voices right now are the December warrant holders that lost out. For investors coming to this board for info, please keep that in mind. You can't expect them to see the positives in the fact that Titan has completed SPORT and will be starting clinical trials. The product is key, if it performs in trials over the next 5 months, the sky is the limit.

I've got something to help, Titan has developed and finished the product. They have produced a product and gotten us as close as we've ever been to commercialization. The only thing left is to get it in a patient and that it works.

Great point, we do have a product and that is something that is completely lost by some on this board.

To see what a physician thinks of surgibot check out

@drpatrickuae on Twitter

How long before it gets back up to $14/share which was the PPS about a year ago? Currently trading at $2 and loose change

A dr at duke mentioned that he couldn't even use the 3D option w surgibot and that the 27mm incision is way too much. That sounds clunky. SPORT is not clunky.

The SurgiQuest AirSeal could be a potential solution to the smoke evacuation

Hopefully w sport, all the techs in the room will be able to experience the same surgical site as the operating physician. IMO big improvement for all involved

http://www.titanmedicalinc.com/investor-relations/sport-clips/

Hargrove has negotiated the deals w cadence, SAIL, longtai and the worldwide supplier of end effectors. Seems pretty effective.

Who negotiated the deals w cadence, longtai, the world wide supplier of end effectors, Sail Training center? It was Hargrove, seems that he has been doing that work

The only thing that matters is the product. If they get it right and the clinical trials go well, all investors will make a big return on their investment.

The true longs know this investment is all about the final product and everything else is window dressings. All the other posters that talked about the market growth and the potential suitors were spot on. We are 5 months away from completing clinical trails, that's the goal line. This mgmt team has to deliver the product not the PRs

I see a mgmt team that has gotten Titan to the goal line and SPORT is this close to commercialization. I see a mgmt team that has delivered a finished product.

In sharing info on the competitive landscape that Titan/Sport are entering, I saw that a physician tried surgibot and described it as a "robotized" Monoport Device - not a surgical robotic platform. mentioned that the size of the incision (27MM!) would be a brake for physicians when considering it. Also, optics need to be better. It's good to know that Titan will have a 19MM incision and state of the art optics.

I agree w timesyours. My opinion on mgmt: they have gotten us further in the last 2 years in the development of sport and closer to commercialization then the previous mgmt/ceo. Having a product that works and is a significant upgrade than what is available are the 2 MAIN priorities of this ceo and mgmt group. I for one am ok w them putting effort into the product rather than appeasing the investor. Warrant holders took a gamble and should have exercised them when the pps was up but chose not too, that's their fault not mgmts.